European Cancer Congress (ECC) 2013, Amsterdam 27 September – 1 October 2013 Abstract ID 966 Poster Board P238 An innovative approach for in vivo isolation of circulating tumor cells (CTCs)

Source URL: www.gilupi.de

• Oncology
• Circulating tumor cell
• Ribbon symbolism
• Prostate cancer
• Breast cancer
• Cancer staging
• Lung cancer
• Immunohistochemistry
• Medicine
• Anatomical pathology
• Anatomy

For immediate release February 22, 2012 Shionogi & Co., Ltd. Eli Lilly Japan K.K. Serotonin/Noradrenalin Reuptake Inhibitor Cymbalta® Capsule 20 mg, 30mg

Source URL: shionogi616.tew-staging.com

• Organic chemistry
• Duloxetine
• Thiophenes
• Shionogi
• Antidepressant
• Neuropathic pain
• Methadone
• Analgesic
• Eli Lilly and Company
• Chemistry
• Amines

IExpansion Project, map - Business meeting - Iconstruction staging, Oct. 9, 2014

Source URL: projects.511wi.gov

FOR IMMEDIATE RELEASE U. S. FOOD AND DRUG ADMINISTRATION ACCEPTS SHIONOGI’S OSPEMIFENE NEW DRUG APPLICATION IN VULVAR AND VAGINAL ATROPHY Potential First Oral Alternative to Vaginal Estrogen Treatments FLORHAM PARK, N

Source URL: shionogi616.tew-staging.com

• Anatomy
• Pain
• Sexual arousal
• Dyspareunia
• Vaginal lubrication
• Menopause
• Estrogen
• Vulva
• Shionogi
• Human reproduction
• Reproductive system
• Female reproductive system

Data from VIKING-3 Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, November 14, Shionogi & Co., Ltd. (Head Office: Osaka; President & C

Source URL: shionogi616.tew-staging.com

• Enzymes
• Integrase
• Microbiology
• Virology
• ViiV Healthcare
• Intel Viiv
• Shionogi
• Dolutegravir
• HIV
• Integrase inhibitors
• Biology
• Organofluorides

Microsoft Word - CUVPOSA Commercial Availability Press Release FINALFor Shionogi Website

Source URL: shionogi616.tew-staging.com

• Piperidines
• Alcohols
• Janssen Pharmaceutica
• Piperazines
• Megacolon
• Rosuvastatin
• Haloperidol
• Norfloxacin
• Loratadine
• Chemistry
• Organic chemistry
• Organochlorides

Shionogi Announces the Conducting of an International Industry-academic Collaboration, SHIONOGI Science Program 2012, and a Drug Discovery Competition, FINDS 2012 Osaka, October 1, 2012 – Shionogi & Co., Ltd. (Head Off

Source URL: shionogi616.tew-staging.com

• Shionogi
• Clinical research
• Medicinal chemistry
• Drug discovery
• Pharmaceutical sciences
• Pharmacology
• Pharmacy

PDF Document

Source URL: shionogi616.tew-staging.com

• Medicine
• Intel Viiv
• Integrase
• ViiV Healthcare
• Shionogi
• New Drug Application
• HIV
• Food and Drug Administration
• Dolutegravir
• Integrase inhibitors
• Pharmaceutical sciences
• Biology

Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Source URL: shionogi616.tew-staging.com

• Organic chemistry
• Organofluorides
• Gilead Sciences
• Cyclopropanes
• Purines
• Abacavir/lamivudine
• Abacavir
• Lamivudine
• Fixed-dose combination
• Medicine
• Chemistry
• Fixed dose combination

Shionogi & Co., Ltd. Shionogi & Co., Ltd. to Commence a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited Osaka, Japan, August 31, Shionogi & Co., Ltd. (Head Office: Osaka; President

Source URL: shionogi616.tew-staging.com

• Economy of Asia
• Asia
• Shionogi
• Economy of Singapore
• Singapore Exchange